Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation.

Moses W, Weng J, Khanafshar E, Duh QY, Clark OH, Kebebew E.

J Surg Res. 2010 May 15;160(2):179-83. doi: 10.1016/j.jss.2009.05.031. Epub 2009 Jun 17.

PMID:
19765726
2.

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.

Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.

Cancer. 2005 Jun 1;103(11):2261-8. Review.

4.

Molecular genetics of papillary thyroid carcinoma: great expectations.

Trovisco V, Soares P, Preto A, Castro P, Máximo V, Sobrinho-Simões M.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):643-53. Review.

5.

[Genetic factors predisposing to the development of papillary thyroid cancer].

Puzianowska-Kuźnicka M, Pietrzak M.

Endokrynol Pol. 2005 May-Jun;56(3):339-45. Review. Polish.

PMID:
16350729
6.

Lessons from mouse models of thyroid cancer.

Kim CS, Zhu X.

Thyroid. 2009 Dec;19(12):1317-31. doi: 10.1089/thy.2009.1609. Review.

7.

Diffuse sclerosing variant of papillary thyroid carcinoma--an update of its clinicopathological features and molecular biology.

Pillai S, Gopalan V, Smith RA, Lam AK.

Crit Rev Oncol Hematol. 2015 Apr;94(1):64-73. doi: 10.1016/j.critrevonc.2014.12.001. Epub 2014 Dec 18. Review.

PMID:
25577570
8.

Molecular analysis of thyroid tumors.

Bhaijee F, Nikiforov YE.

Endocr Pathol. 2011 Sep;22(3):126-33. doi: 10.1007/s12022-011-9170-y. Review.

PMID:
21739166
9.

ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.

Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M.

Eur J Endocrinol. 2016 Apr;174(4):R117-26. doi: 10.1530/EJE-15-0605. Epub 2015 Oct 28. Review.

10.

Molecular diagnosis of carcinomas of the thyroid gland.

de Biase D, Visani M, Pession A, Tallini G.

Front Biosci (Elite Ed). 2014 Jan 1;6:1-14. Review.

PMID:
24389136
11.

New therapies for dedifferentiated papillary thyroid cancer.

Fallahi P, Mazzi V, Vita R, Ferrari SM, Materazzi G, Galleri D, Benvenga S, Miccoli P, Antonelli A.

Int J Mol Sci. 2015 Mar 17;16(3):6153-82. doi: 10.3390/ijms16036153. Review.

12.

Molecular analysis of thyroid tumors.

Nikiforov YE.

Mod Pathol. 2011 Apr;24 Suppl 2:S34-43. doi: 10.1038/modpathol.2010.167. Review.

13.

Thyroid cancer in 2015: Molecular landscape of thyroid cancer continues to be deciphered.

Nikiforov YE.

Nat Rev Endocrinol. 2016 Feb;12(2):67-8. doi: 10.1038/nrendo.2015.217. Epub 2015 Dec 15. Review. No abstract available.

PMID:
26668120
14.

Modeling anaplastic thyroid carcinoma in the mouse.

Champa D, Di Cristofano A.

Horm Cancer. 2015 Feb;6(1):37-44. doi: 10.1007/s12672-014-0208-8. Epub 2014 Nov 25. Review.

15.

Familial nonmedullary thyroid carcinoma.

Malchoff CD, Malchoff DM.

Cancer Control. 2006 Apr;13(2):106-10. Review.

PMID:
16735984
16.

Thyroid cancer gender disparity.

Rahbari R, Zhang L, Kebebew E.

Future Oncol. 2010 Nov;6(11):1771-9. doi: 10.2217/fon.10.127. Review.

17.

Update on the molecular diagnosis and targeted therapy of thyroid cancer.

Liu M, Ruan M, Chen L.

Med Oncol. 2014 Jun;31(6):973. doi: 10.1007/s12032-014-0973-9. Epub 2014 May 1. Review.

PMID:
24788398
18.

Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms.

Wynford-Thomas D.

Horm Res. 1997;47(4-6):145-57. Review.

PMID:
9167946
19.

Delivery of small interfering RNA. A review and an example of application to a junction oncogene.

Ramon AL, Bertrand JR, Malvy C.

Tumori. 2008 Mar-Apr;94(2):254-63. Review.

PMID:
18564614
20.

RAS mutations in thyroid cancer.

Howell GM, Hodak SP, Yip L.

Oncologist. 2013;18(8):926-32. doi: 10.1634/theoncologist.2013-0072. Epub 2013 Jul 19. Review.

Supplemental Content

Support Center